Abingdon Health Plc

ABDX · LSE · Healthcare / Diagnostics & Research

8.50GBX+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close8.50

Open8.50

Day Range8.16 – 9.00

52-Week Range5.50 – 13.00

Volume57.01K

Market Cap27.80M

P/E (TTM)0.00

Forward P/E208.33

EPS-0.01

Dividend Yield0.00%

Beta0.14

50-Day Avg10.62

200-Day Avg9.23

About

Abingdon Health Plc develops, manufactures, and distributes diagnostic devices in the United Kingdom, Europe, the United States, Canada, and internationally. It operates through Contract Development, Contract Manufacturing, Product Sales, and Regulatory segments. The company provides a range of professional-use tests and self-tests to various industries, including healthcare, COVID-19, plant health, and nucleic acid detection. Abingdon Health Plc was incorporated in 2008 and is based in York, the United Kingdom.

Company Details

SectorHealthcare
IndustryDiagnostics & Research
CEODr. Christopher William Hand
Employees129
HeadquartersYork Biotech Campus, York, United Kingdom, YO41 1LZ, UK
Websitehttps://www.abingdonhealth.com

Leadership

Dr. Christopher William HandExecutive Chairman · b. 1961
Mr. Thomas Edward HayesSecretary, CFO & Director · b. 1976
Mr. Chris Henry Francis YatesPresident of & Director Abingdon Health USA Inc. · b. 1974
Mr. Mark JonesChief Operating Officer
Ms. Nina GarrettChief Technical Officer
Laura TowseController

Financials

Income Statement

Currency: GBP	2016-12-31	2018-06-30	2019-06-30	2020-06-30	2021-06-30	2022-06-30	2023-06-30	2024-06-30	2025-06-30
Total Revenue	1.39M	2.27M	2.28M	5.24M	11.62M	2.83M	4.04M	6.13M	8.43M
Growth (%)	-	+63.12%	+0.39%	+129.88%	+121.93%	-75.60%	+42.68%	+51.67%	+37.39%
Cost of Revenue	333.40K	924.61K	705.38K	1.15M	8.22M	8.06M	2.64M	2.46M	5.30M
Gross Profit	1.06M	1.34M	1.57M	4.09M	3.39M	-5.23M	1.40M	3.68M	3.13M
Gross Margin	76.03%	59.24%	69.03%	78.05%	29.21%	-184.44%	34.66%	59.97%	37.11%
Operating Expense	3.46M	6.05M	2.97M	3.87M	8.91M	6.88M	5.25M	5.05M	7.15M
Operating Income	-2.40M	-4.70M	-1.40M	217.00K	-5.52M	-12.11M	-3.85M	-1.37M	-4.03M
Operating Margin	-172.75%	-207.34%	-61.28%	4.15%	-47.51%	-426.98%	-95.08%	-22.38%	-47.75%
EBITDA	-	8.00M	-1.10M	-2.84M	-6.07M	-19.98M	-2.81M	-916.00K	-3.12M
EBITDA Margin	-	352.66%	-48.43%	-54.32%	-52.26%	-704.73%	-69.49%	-14.93%	-37.04%
Net Income	-3.18M	3.47M	-1.26M	-3.37M	-6.97M	-21.26M	-3.47M	-1.27M	-3.42M
Net Income Margin	-228.89%	152.95%	-55.33%	-64.45%	-60.02%	-749.98%	-85.76%	-20.72%	-40.51%
R&D	-	285.04K	210.73K	854.00K	503.00K	182.00K	-	-	-
R&D as % of Total Revenue	-	12.57%	9.25%	16.31%	4.33%	6.42%	-	-	-
Interest Expense	0	4.39M	22.43K	65.00K	234.00K	69.00K	75.00K	57.00K	75.00K
Interest Expense % of Total Revenue	0.00%	193.32%	0.98%	1.24%	2.01%	2.43%	1.85%	0.93%	0.89%

Balance Sheet

Currency: GBP	2016-12-31	2018-06-30	2019-06-30	2020-06-30	2021-06-30	2022-06-30	2023-06-30	2024-06-30	2025-06-30
Total Assets	8.60M	6.92M	7.33M	10.97M	33.23M	12.77M	6.06M	5.09M	9.31M
Total Liabilities	8.72M	1.11M	1.24M	8.22M	11.90M	6.34M	3.05M	2.84M	4.01M
Total Equity	-115.66K	5.81M	6.09M	2.75M	21.33M	6.43M	3.01M	2.25M	5.30M
Cash	2.03M	476.91K	866.15K	4.39M	4.98M	2.40M	3.24M	1.44M	1.92M
Total Debt	7.57M	570.43K	503.62K	4.77M	1.50M	1.28M	1.02M	1.05M	1.03M
Net Debt	-	93.52K	-362.53K	383.47K	-3.48M	-1.12M	-2.22M	-391.00K	-890.00K

Cash Flow

Currency: GBP	2016-12-31	2018-06-30	2019-06-30	2020-06-30	2021-06-30	2022-06-30	2023-06-30	2024-06-30	2025-06-30
Operating Cash Flow	-1.66M	-2.55M	-908.25K	2.10M	-12.88M	-7.74M	1.00M	-1.66M	-3.18M
Investing Cash Flow	-834.21K	-357.97K	-79.24K	-1.94M	-7.28M	-760.00K	-156.00K	-23.00K	-1.43M
Financing Cash Flow	2.80M	1.35M	1.38M	3.37M	20.74M	5.92M	-7.00K	-114.00K	5.08M
Capital Expenditure	668.90K	358.69K	96.22K	1.65M	7.25M	760.00K	157.00K	41.00K	327.00K
Free Cash Flow	-	-2.91M	-1.00M	445.00K	-20.13M	-8.49M	845.00K	-1.70M	-3.43M
FCF to OCF	-	114.06%	110.59%	21.24%	156.31%	109.83%	84.33%	102.47%	107.86%

Earnings

Report Date	Dec 15, 2020	Mar 9, 2021	Nov 18, 2021	Mar 29, 2022	Nov 24, 2022	Mar 31, 2023	Mar 24, 2025	Nov 11, 2025	Apr 1, 2026
EPS Estimate	0.00	0.00	0.00	0.00	-	-	0.00	0.00	0.00
EPS Actual	-0.04	-0.01	-0.07	-0.02	-0.13	-0.02	-0.01	-0.89	0.00
Surprise	-	-	-	-	-	-	-	-	-
Timing	Pre-market	Pre-market	-	Pre-market	Pre-market	After-hours	-	-	-

Key Statistics & Ratios

Market Cap27.80M

Enterprise Value23.78M

Trailing P/E0.00

Forward P/E208.33

Price / Sales2.90

Price / Book4.21

EPS-0.01

Book Value0.015

Revenue (TTM)9.57M

Gross Profit (TTM)3.96M

EBITDA-3.42M

Profit Margin-33.88%

Operating Margin-53.88%

Return on Equity-50.98%

Return on Assets-24.37%

Shares Outstanding252.75M

Shares Float168.65M

Beta0.14

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Stock Splits

Dec 2, 2021673:671